Related Experiment Video

Updated: Jul 15, 2026

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
06:57

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

Published on: February 20, 2020

Immune mediated hemolysis in visceral leishmaniasis

Vikas Mahajan1, R K Marwaha

  • 1Department of Pediatric Hematology and Oncology, Advanced Pediatric Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Journal of Tropical Pediatrics
|May 8, 2007
PubMed

Insights

Visceral leishmaniasis can cause anemia, but immune hemolytic anemia is rare. This case study shows successful treatment of a child with this condition using liposomal amphotericin.

Area of Science:

  • Tropical medicine
  • Pediatric hematology
  • Infectious diseases

Background:

  • Visceral leishmaniasis (VL) is a parasitic disease endemic in many tropical regions.
  • Anemia is a common complication of VL, but immune hemolytic anemia is rarely reported.
  • Understanding rare complications of VL is crucial for effective patient management.

Observation:

  • A young child presented with symptoms suggestive of visceral leishmaniasis.
  • The child developed Coombs-positive hemolytic anemia, an uncommon manifestation of VL.
  • This immune hemolytic anemia was diagnosed in the context of active visceral leishmaniasis.

Findings:

  • Immune hemolytic anemia was confirmed in a pediatric patient with visceral leishmaniasis.
  • The anemia was characterized as Coombs-positive, indicating an autoimmune process.
  • Successful treatment of both VL and the hemolytic anemia was achieved.

Implications:

  • This case highlights the importance of considering immune hemolytic anemia in pediatric VL.
  • Prompt diagnosis and appropriate treatment, such as liposomal amphotericin, are vital.
  • Further research may elucidate the mechanisms linking VL and autoimmune hemolytic anemia.

More Related Videos

Intravital Microscopy Imaging of the Liver following Leishmania Infection: An Assessment of Hepatic Hemodynamics10:48

Intravital Microscopy Imaging of the Liver following Leishmania Infection: An Assessment of Hepatic Hemodynamics

Published on: July 28, 2015

Related Concept Videos

Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...